Correlation Between Merck and Alto Neuroscience,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Alto Neuroscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Alto Neuroscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Alto Neuroscience,, you can compare the effects of market volatilities on Merck and Alto Neuroscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Alto Neuroscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Alto Neuroscience,.

Diversification Opportunities for Merck and Alto Neuroscience,

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Merck and Alto is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Alto Neuroscience, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alto Neuroscience, and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Alto Neuroscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alto Neuroscience, has no effect on the direction of Merck i.e., Merck and Alto Neuroscience, go up and down completely randomly.

Pair Corralation between Merck and Alto Neuroscience,

Considering the 90-day investment horizon Merck Company is expected to generate 0.19 times more return on investment than Alto Neuroscience,. However, Merck Company is 5.13 times less risky than Alto Neuroscience,. It trades about -0.06 of its potential returns per unit of risk. Alto Neuroscience, is currently generating about -0.04 per unit of risk. If you would invest  12,408  in Merck Company on November 3, 2024 and sell it today you would lose (2,526) from holding Merck Company or give up 20.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Alto Neuroscience,

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Merck is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Alto Neuroscience, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alto Neuroscience, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Alto Neuroscience, displayed solid returns over the last few months and may actually be approaching a breakup point.

Merck and Alto Neuroscience, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Alto Neuroscience,

The main advantage of trading using opposite Merck and Alto Neuroscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Alto Neuroscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will offset losses from the drop in Alto Neuroscience,'s long position.
The idea behind Merck Company and Alto Neuroscience, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world